Mesenchymal Stem Cells Suppressed Skin and Lung Inflammation and Fibrosis in Topoisomerase I-induced Systemic Sclerosis Associated with Lung Disease Mouse Model

Researchers investigated the therapeutic effects and mechanisms of treatment of bone marrow-MSC derived from C57BL/6 on the topoisomerase I induced systemic sclerosis associated with lung interstitial lung disease like mice model.